个人中心| | 帮助
高级检索
当前位置： 首页 > 详情页

Development and therapeutic potential of adaptor-associated kinase 1 inhibitors in human multifaceted diseases

| 认领 | 导出 | |

文献详情

资源类型：
Pubmed体系：
作者：
Xin Xin[1] * ; Wang Yue[2] * ; Zhang Lele[1] * ; Zhang Dan[1] ; Sha Leihao[1] ; Zhu Ziyu[1] ; Huang Xiaoyi[1] ; Mao Wuyu[1] ; Zhang Jifa[1] ;
机构： [1]Joint Research Institution of Altitude Health, State Key Laboratory of Biotherapy and Cancer Center, Department of Respiratory and Critical Care Medicine, Institute of Respiratory Health, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu, 610041, Sichuan, China [2]Leling Traditional Chinese Medicine Hospital, Leling, 253600, Shandong, China
出处：
DOI： 10.1016/j.ejmech.2023.115102
ISSN：

关键词： AAK1 Small molecule inhibitors Structure-activity relationships (SARs) Anti-neuropathic pain Broad-spectrum antiviral target

摘要：
Adaptor-Associated Kinase 1 (AAK1), a Ser/Thr protein kinase, responsible for regulating clathrin-mediated endocytosis, is ubiquitous in the central nervous system (CNS). AAK1 plays an important role in neuropathic pain and a variety of other human diseases, including viral invasion, Alzheimer's disease, Parkinson's syndrome, etc. Therefore, targeting AAK1 is a promising therapeutic strategy. However, although small molecule AAK1 inhibitors have been vigorously developed, only BMS-986176/LX-9211 has entered clinical trials. Simultaneously, new small molecule inhibitors, including BMS-911172 and LP-935509, exhibited excellent druggability. This review elaborates on the structure, biological function, and disease relevance of AAK1. We emphatically analyze the structure-activity relationships (SARs) of small molecule AAK1 inhibitors based on different binding modalities and discuss prospective strategies to provide insights into novel AAK1 therapeutic agents for clinical practice.Copyright © 2023. Published by Elsevier Masson SAS.

基金：
National Natural Science Foundation of China (81903502, 22277083), and Natural Science Foundation of Sichuan Province (2022NSFSC1365, 2022NSFSC1187).
语种：
外文
PubmedID：
中科院(CAS)分区：
出版当年[2023]版：
大类 | 2 区 医学
小类 | 1 区 药物化学
最新[2023]版：
大类 | 2 区 医学
小类 | 1 区 药物化学
第一作者：
第一作者机构： [1]Joint Research Institution of Altitude Health, State Key Laboratory of Biotherapy and Cancer Center, Department of Respiratory and Critical Care Medicine, Institute of Respiratory Health, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu, 610041, Sichuan, China
共同第一作者：
通讯作者：
推荐引用方式(GB/T 7714)：
Xin Xin,Wang Yue,Zhang Lele,et al.Development and therapeutic potential of adaptor-associated kinase 1 inhibitors in human multifaceted diseases[J].European journal of medicinal chemistry.2023,248:115102.doi:10.1016/j.ejmech.2023.115102.
APA：
Xin Xin,Wang Yue,Zhang Lele,Zhang Dan,Sha Leihao...&Zhang Jifa.(2023).Development and therapeutic potential of adaptor-associated kinase 1 inhibitors in human multifaceted diseases.European journal of medicinal chemistry,248,
MLA：
Xin Xin,et al."Development and therapeutic potential of adaptor-associated kinase 1 inhibitors in human multifaceted diseases".European journal of medicinal chemistry 248.(2023):115102

相关文献

[1]医院后勤精细化管理策略研究 [2]个性化目标教学在神经外科护理实习生带教中的应用 [3]纳米增强免疫比浊法和高效液相色谱法检测化疗患者5-氟尿嘧啶血药浓度的比较 [4]徒手淋巴引流对乳腺癌术后淋巴水肿的治疗效果分析 [5]护理干预在减轻妇科恶性肿瘤腹部术后疼痛中的效果 [6]心理护理对肿瘤介入治疗患者生活质量的影响 [7]某院2400张门诊中成药处方分析 [8]人文关怀在恶性肿瘤护理中的应用效果分析 [9]综合护理干预对肺癌化疗患者生活质量的影响 [10]外涂万花油对化疗性静脉炎的预防及疗效

资源点击量：52808 今日访问量：0 总访问量：4561 更新日期：2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 四川省肿瘤医院 技术支持：重庆聚合科技有限公司 地址：成都市人民南路四段55号